PT  - JOURNAL ARTICLE
AU  - Bi, Qifang
AU  - Dickerman, Barbra A.
AU  - McLean, Huong Q.
AU  - Martin, Emily T.
AU  - Gaglani, Manjusha
AU  - Wernli, Karen J.
AU  - Goundappa, Balasubramani
AU  - Flannery, Brendan
AU  - Lipsitch, Marc
AU  - Cobey, Sarah
AU - the US Flu Vaccine Effectiveness Network Investigators
TI  - Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning
AID  - 10.1101/2023.03.12.23287173
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.12.23287173
4099  - http://medrxiv.org/content/early/2023/03/17/2023.03.12.23287173.short
4100  - http://medrxiv.org/content/early/2023/03/17/2023.03.12.23287173.full
AB  - Background Studies have reported that prior-season influenza vaccination is associated with higher risk of clinical influenza infection among vaccinees in a given season. Understanding the underlying causes requires consideration of within-season waning and recent infection.Methods Using the US Flu Vaccine Effectiveness (VE) Network data over 8 influenza seasons (2011-2012 to 2018-2019), we estimated the effect of prior-season vaccination on the odds of clinical infection in a given season, after accounting for waning vaccine protection using regression methods. We adjusted for potential confounding by recent clinical infection using inverse-probability weighting. We investigated theoretically whether unmeasured subclinical infection in the prior season, which is more likely in the non-repeat vaccinees, could explain the repeat vaccination effect.Results Repeat vaccinees vaccinated earlier in a season by one week. After accounting for waning VE, repeat vaccinees were still more likely to test positive for influenza A(H3N2) (OR=1.11, 95% CI:1.02-1.21) but not for influenza B (OR=1.03, 95% CI:0.89-1.18) or A(H1N1) (OR=1.03, 95% CI:0.90-1.19) compared to those vaccinated in the given season only. Recent clinical infection with the homologous (sub)type protected against clinical infection with A(H3N2) or B. Individuals with clinical infection in one season had 1.11 (95% CI:1.03-1.19) times the odds of switching vaccination status in the following season. Adjusting for recent clinical infections did not strongly influence the estimated effect of prior-season vaccination. Adjusting for subclinical infection could theoretically attenuate this effect.Conclusion Waning protection and recent clinical infection were insufficient to explain observed reduced VE in repeat vaccinees with a test-negative design.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially supported by the Collaborative Influenza Vaccine Innovation Centers (CIVICs) contract 75N93019C00051 (S.C. and Q.B.). ML acknowledges support from US NIH grant 1R01GM139926 to University of Michigan. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the University of Chicago gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData and relevant code are available at https://github.com/cobeylab/FluVE_repeatvac_public